We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.
- Authors
Miyahara, K; Nouso, K; Morimoto, Y; Takeuchi, Y; Hagihara, H; Kuwaki, K; Onishi, H; Ikeda, F; Miyake, Y; Nakamura, S; Shiraha, H; Takaki, A; Honda, M; Kaneko, S; Sato, T; Sato, S; Obi, S; Iwadou, S; Kobayashi, Y; Takaguchi, K
- Abstract
Background:We previously reported that expressions of the pro-angiogenic cytokines angiopoietin-2 (Ang-2), follistatin, granulocyte colony-stimulating factor, hepatocyte growth factor, leptin, platelet-derived growth factor-BB, platelet endothelial cell adhesion molecule-1, and vascular endothelial growth factor were associated with the response to sorafenib in patients with advanced hepatocellular carcinoma (HCC). The aim of the present study is to examine the same relationship in a larger cohort.Methods:In the current retrospective cohort study, we measured serum levels of the eightcytokines in 120 consecutive HCC patients who were treated with sorafenib. We evaluated the effects of increased expression of serum cytokines on progression-free survival (PFS) and overall survival (OS).Results:Elevated expression of Ang-2 correlated both with significantly shorter PFS (hazard ratio (HR), 1.84; 95% confidence interval (CI), 1.21-2.81), and OS (HR, 1.95; 95% CI, 1.21-3.17). Patients with more than three cytokines expressed above the median similarly had significantly shorter PFS (HR, 1.98; 95% CI, 1.30-3.06) and OS (HR, 1.94; 95% CI, 1.19-3.22). Differences in OS were evident in cases with the evidence of macroscopic vascular invasion or extrahepatic metastasis.Conclusion:High expression of Ang-2 or more than cytokines in serum is associated with poor PFS and OS in HCC patients treated with sorafenib.
- Subjects
VASCULAR endothelial growth factors; CYTOKINES; ANGIOPOIETIN-2; FOLLISTATIN; GRANULOCYTE colony stimulating factor receptor; COHORT analysis
- Publication
British Journal of Cancer, 2013, Vol 109, Issue 8, p2072
- ISSN
0007-0920
- Publication type
Article
- DOI
10.1038/bjc.2013.554